Recent advances in practical methods for liver cell biology: a short overview
- Sprache
-
Englisch
- Identifier
-
1215337868
- Beteiligte Personen und Organisationen
-
Torres, Sandra
Abdullah, Zeinab
Brol, Maximilian J.
Hellerbrand, Claus
Fernandez, Mercedes
Fiorotto, Romina
Klein, Sabine
Königshofer, Philipp
Liedtke, Christian
Lotersztajn, Sophie
Nevzorova, Yulia A.
Schierwagen, Robert
Reiberger, Thomas
Uschner, Frank Erhard
Tacke, Frank
Weiskirchen, Ralf
Trebicka, Jonel
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Torres, Sandra
- Abdullah, Zeinab
- Brol, Maximilian J.
- Hellerbrand, Claus
- Fernandez, Mercedes
- Fiorotto, Romina
- Klein, Sabine
- Königshofer, Philipp
- Liedtke, Christian
- Lotersztajn, Sophie
- Nevzorova, Yulia A.
- Schierwagen, Robert
- Reiberger, Thomas
- Uschner, Frank Erhard
- Tacke, Frank
- Weiskirchen, Ralf
- Trebicka, Jonel
Ähnliche Objekte (12)
Mechanisms of liver fibrosis resolution
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Molecular interactions between hepatitis B virus and delta virus
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Role of IL-17 and Th17 cells in liver diseases
Mechanisms of liver fibrosis resolution
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Molecular interactions between hepatitis B virus and delta virus
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Role of IL-17 and Th17 cells in liver diseases
Mechanisms of liver fibrosis resolution
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Molecular interactions between hepatitis B virus and delta virus
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts